Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis

European Journal of Pharmacology

Volumn 470, Issue 1-2, 2003, Pages 103-112

  Maity, Swapna ^a   Ukil, Anindita ^a   Karmakar, Sudipan ^a   Datta, Neeta ^a   Chaudhuri, Tirthankar ^b   Vedasiromoni, Joseph R ^a   Ganguly, Dilip K ^b   Das, Pijush K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Tea Research Association   (India)

Author keywords

Black tea; Colitis; Cytokine; Inflammatory bowel disease; NF B (nuclear factor kappa B); Nitric oxide (NO) synthase, inducible; Thearubigin

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; POLYPHENOL; SERINE PROTEINASE; THEARUBIGIN; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEVERAGE; COLITIS; COLON INJURY; CONTROLLED STUDY; DIARRHEA; DISEASE MODEL; DOSE CALCULATION; DOSE RESPONSE; DRUG MECHANISM; ENTERITIS; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION; HELPER CELL; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TEA; TH1 CELL; UPREGULATION;

EID: 0038360968     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01760-6     Document Type: Article

References (48)

1. Balentine D.A., Wiseman S.A., Bouwens L.C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37:1997;693-704.
2. Chan M.M.Y., Fong D., Ho C.T., Huang H.I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from tea. Biochem. Pharmacol. 54:1997;1281-1286.
3. Chen C.W., Ho C.T. Antioxidant properties of polyphenols extracted from green and black teas. J. Food Lipids. 2:1995;35-46.
4. Crouvezier S., Powell B., Keir D., Yaqoob P. The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro. Cytokine. 13:2001;280-286.
5. Cuzzocrea S., McDonald M.C., Mazzon E., Dugo L., Lepore V., Fonti M.T., Ciccolo A., Terranova M.L., Caputi A.P., Thiemermann C. Tempol, a membrane-permeable radical scavanger, reduces dinitrobenzene sulfonic acid-induced colitis. Eur. J. Pharmacol. 406:2000;127-137.
6. Feretti M., Gionchetti P., Rizello F., Venturi A., Stella P., Corti F., Mizrahi J., Miglioli M., Campieri M. Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis. Dig. Dis. Sci. 42:1997;2606-2611.
7. Fuss I.J., Marth T., Neurath M.F., Perlstein G.R., Jain A., Strober W. Anti-interleukin 12 treatment regulates apoptosis of Th1 cells in experimental colitis in mice. Gastroenterology. 117:1999;1078-1088.
8. Godkin A.J., De Belder A.J., Villa L., Wong A., Beesley J.E., Kane S.P., Martin J.F. Expression of nitric oxide synthase in ulcerative colitis. Eur. J. Clin. Investig. 26:1996;867-872.
9. Gunawardana S.C., Jergens A.E., Ahrens F.A., Niyo Y. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease. J. Am. Vet. Med. Assoc. 211:1997;318-321.
10. Hanauer S.B. Inflammatory bowel disease. N. Engl. J. Med. 334:1996;841-848.
11. Hawkins J.V., Emmel E.L., Feuer J.J., Nedelman M.A., Harvey C.J., Klein H.J., Rozmiarek H., Kennedy A.R., Lichtenstein G.R., Billings P.C. Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig. Dis. Sci. 42:1997;1969-1980.
12. Ho C.T., Chen Q., Shi H., Zhang K.Q., Rosen R.T. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev. Med. 21:1992;520-525.
13. Hogaboam C.M., Jacobson K., Collins S.M., Blennerhassett M.G. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268:1995;G673-G684.
14. Hogaboam C.M., Vallance B.A., Kumar A., Addison C.L., Graham F.L., Gauldie J., Collins S.M. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100:1997;2766-2776.
15. Katiyar S.K., Mukhtar H. Tea and chemoprevention of cancer. Int. J. Oncol. 8:1996;221-238.
16. Kawakami K., Tohyama M., Qifeng X., Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1997;1307-1312.
17. Kim H.K., Cheon B.S., Kim Y.H., Kim H.P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure activity relationships. Biochem. Pharmacol. 58:1999;759-765.
18. Kimura H., Miura S., Shigematsu T., Ohkubo N., Tsuzuki Y., Kurose I., Higuchi H., Akiba Y., Hokari R., Hirokawa M., Serizawa H., Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 42:1997;1047-1054.
19. Kirsner J.B., Shorter R.G. Inflammatory Bowel Disease. 3rd ed. 1988;Lea & Febiger, Philadelphia.
20. Laszlo F., Whittle B.J. Colonic microvascular integrity in acute endotoxaemia: interactions between constitutive nitric oxide and 5-lipoxygenase products. Eur. J. Pharmacol. 277:1995;R1-R3.
21. Lin Y.L., Juan I.M., Chen Y.L., Liang Y.C., Lin J.K. Composition of polyphenols in fresh tealeaves and associations of their oxygen radical-absorbing capacity with antiproliferative actions in fibroblast cells. J. Agric. Food Chem. 44:1996;1387-1394.
22. Lin Y.L., Tsai S.H., LinShiau S.Y., Ho C.T., Lin J.K. Theaflavin digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappa B in macrophages. Eur. J. Pharmacol. 367:1999;379-388.
23. Lodovici M., Casalini C., De Filipo C., Copeland E., Xu X., Clifford M., Dolara P. Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage in rat colon mucosa by black tea complex polyphenols. Food Chem. Toxicol. 38:2000;1085-1088.
24. Lundberg J.O., Hellstrom P.M., Lundberg J.M., Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet. 344:1994;1673-1674.
25. - production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol. 105:1984;358-365.
26. McCafferty D.M., Mudgett J.S., Swain M.G., Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 112:1997;1022-1027.
27. McKenzie S.J., Baker M.S., Buffinton G.D., Doe W.F. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J. Clin. Invest. 98:1996;136-141.
28. Miller M.J., Sadowska K., Chotinaruemol S., Kakkis J.L., Clark D.A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther. 264:1993;11-16.
29. Morris G.P., Beck P.I., Herridge M.S., Depew W.T., Szewczuk M.R., Wallace J.L. Haptene-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:1989;795-803.
30. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1996;3051-3064.
31. Neilly P.J., Kirk S.J., Gardiner K.R., Anderson N.H., Rowlands B.J. Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br. J. Surg. 82:1995;1188-1191.
32. Neilly P.J., Gardiner K.R., Rowlands B.J. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut. 38:1996;475-479.
33. Neurath M.F., Fuss I.J., Kelsall B.I., Stuber E., Strober W. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1995;1281-1290.
34. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the P65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2:1996;998-1004.
35. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
36. Parronchi P., Romagnani P., Annunziato F., Sampugnaro S., Becchio A., Giannarini L., Maggi E., Pupilli C., Tonelli F., Romagnani S. Type 1 helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150:1997;823-832.
37. Pfeiffer C.J., Qiu B.S. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J. Pharm. Pharmacol. 47:1995;827-832.
38. Rachmilewitz D., Karmeli F., Okon E., Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut. 37:1995;247-255.
39. Rachmilewitz D., Stamler J.S., Bachwich D., Karmeli F., Ackerman Z., Podolsky D.K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn' disease. Gut. 36:1995;718-723.
40. Rice-Evans C.A., Miller N.J. Antioxidant activities of flavonoids as bioactive components of food. Biochem. Soc. Trans. 24:1996;790-795.
41. Sarkar A., Bhaduri A.N. Black tea is a powerful chemopreventor of reactive oxygen and nitrogen species: comparison with its individual catechin constituents and green tea. Biochem. Biophys. Res. Commun. 284:2001;173-178.
42. Shiraki M., Hara Y., Osawa T., Kumon H., Nakauama T., Kawakishi S. Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat. Res. 323:1994;29-34.
43. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 111:1996;871-885.
44. Wallace J.L., Keenan C.M. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am. J. Physiol. 258:1990;G527-G534.
45. Yang C.S., Wang Z.Y. Tea and cancer. J. Natl. Cancer Inst. 85:1993;1038-1049.
46. Yang F., De Villers W.J.S., McClain C., Varilek G.W. Green tea polyphenols block endotoxin-induced TNF production and lethality in a murine model. J. Nutr. 128:1998;2334-2340.
47. Zingarelli B., Day B.J., Crapo J., Salzman A.L., Szabo C. The potential involvement of peroxynitrite in the pathogenesis of endotoxic shock. Br. J. Pharmacol. 120:1997;259-267.
48. Zingarelli B., Cuzzocrea S., Szabo C., Salzman A.L. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavanger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 287:1998;1048-1055.